MGRO — MustGrow Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$55.77m
- CA$53.29m
- CA$0.40m
Annual cashflow statement for MustGrow Biologics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.31 | -3.06 | -5.57 | -0.677 | -4.89 |
| Non-Cash Items | 0.718 | 0.324 | 1.7 | 0.926 | 1.47 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.014 | 0.329 | 0.604 | -0.544 | -0.164 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.58 | -2.41 | -3.26 | -0.295 | -3.58 |
| Financing Cash Flow Items | 0.036 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.86 | 8.72 | 0.654 | 0.096 | -0.241 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.716 | 6.31 | -2.6 | -0.199 | -3.82 |